Aggression and disruptive behavior disorders in children and adolescents

Expert Review of Neurotherapeutics

Volumn 4, Issue 4, 2004, Pages 623-632

  Turgay, Atilla ^a,b  

^a SCARBOROUGH HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Aggression; Children; Disruptive behavioral disorders; Evaluation; Prevention; Treatment

Indexed keywords

AMFEBUTAMONE; AMPHETAMINE; ANXIOLYTIC AGENT; ATOMOXETINE; CEPHALON; CLONIDINE; DESIPRAMINE; DEXMETHYLPHENIDATE; FLUOXETINE; GUANFACINE; IMIPRAMINE; LITHIUM; METHYLPHENIDATE; MOOD REGULATOR; NEUROLEPTIC AGENT; PSYCHOSTIMULANT AGENT; RISPERIDONE; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; VALPROATE SEMISODIUM;

ADOLESCENCE; ADOLESCENT; AGGRESSION; ANTISOCIAL BEHAVIOR; ANXIETY DISORDER; ATTENTION DEFICIT DISORDER; AUTISM; BEHAVIOR DISORDER; BEHAVIOR THERAPY; BIPOLAR DISORDER; CHILD; CHILD BEHAVIOR; CLINICAL TRIAL; COMMUNITY CARE; COMORBIDITY; CONDUCT DISORDER; DEVELOPMENTAL DISORDER; DIABETES MELLITUS; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DISRUPTIVE BEHAVIOR; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DYSTHYMIA; EDUCATION; ENDOCRINE DISEASE; EPILEPSY; FAMILY COUNSELING; FATIGUE; GILLES DE LA TOURETTE SYNDROME; HUMAN; HYPERTHYROIDISM; INTERMITTENT EXPLOSIVE DISORDER; INTERVIEW; MAJOR DEPRESSION; MEDICAL DOCUMENTATION; MENTAL DEFICIENCY; MENTAL DISEASE; MOOD DISORDER; OPPOSITIONAL DEFIANT DISORDER; ORGANIC BRAIN SYNDROME; PARENT; PERSONALITY DISORDER; PSYCHODYNAMIC PSYCHOTHERAPHY; PSYCHOEDUCATION; PSYCHOSOCIAL CARE; PSYCHOTHERAPY; QUALITY OF LIFE; RATING SCALE; REVIEW; SCHOOL; SIDE EFFECT; TEACHER; WEIGHT GAIN;

ADOLESCENT; AGGRESSION; ATTENTION DEFICIT AND DISRUPTIVE BEHAVIOR DISORDERS; CHILD; CHILD BEHAVIOR DISORDERS; CONDUCT DISORDER; DIAGNOSIS, DIFFERENTIAL; HUMANS;

EID: 3042742535     PISSN: 14737175     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737175.4.4.623     Document Type: Review

References (76)

1. Tremblay R, McCord J, Boileau H, Charlebois P. Can disruptive boys be helped to become competent? Psychiatry 54, 148-161 (1991).
2. Tremblay RE, Pihl RO, Vitaro F, Dobkin PL. Predicting early onset of male antisocial behavior from preschool behavior. Arch. Gen. Psychiatry 51, 732-739 (1994).
3. American Academy of Child and Adolescent Psychiatry Official Action Group. Practice parameters for the assessment and treatment of children and adolescents with conduct disorder. J. Am. Acad. Child. Adolesc. Psychiatry 36, S122-S139 (1997).
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fourth Edition (DSM-IV. American Psychiatric Association, Washington DC, USA (1994).
5. Turgay A, Morgan A, Mok L, Ng D. Chronic and serious aggressive behavior in children and adolescents are commonly associated with psychiatric disorders. Paediatr. Child. Health. 6(Suppl. A), 14 (2001).
6. Offord DR, Boyle MH, Sztmari P et al. Ontario Child Health Study II: six months prevalence of disorder and rates of service utilization. Arch. Gen. Psychiatry 44, 832-836 (1987).
7. Gadow KD, Sprafkin J. Child Symptom Inventory. Checkmate Plus, NY, USA (1987).
8. Robins LN. Deviant Children Grown-Up. Williams & Wilkins, MD, USA (1966).
9. Frick PJ. Family dysfunction and the disruptive disorders: a review of recent empirical findings. In: Advances In Clinical Child Psychology. Ollendick TH, Prinz RJ, (Eds). Plenum, NY, USA, 203-226 (1994).
10. Kazdin A. Conduct Disorders in Childhood and Adolescence. Sage Publications, CA, USA (1995).
11. Lahey BB, Loeber R, Quay HC, Frick PJ, Grimm J. Oppositional defiant disorder and conduct disorder. In: DSM-IV Sourcebook. Volume Three. Widiger TA, Frances AJ, Pincus HA, Ross R, First MB, Davis W (Eds). American Psychiatric Association, Washington DC, USA, 189-209 (1997).
12. Lahey BB, Loeber R, Quay HC et al. Validity of DSM-IV subtypes of conduct disorder based on age of onset. J. Am. Acad. Child. Adolesc. Psychiatry 37, 435-442 (1998).
13. Hill J, Maughan B. Conduct Disorders in Childhood and Adolescence. Cambridge University Press, Cambridge, UK (2001).
14. Pliszka SR, Carlson CL, Swanson JM. ADHD With Comorbid Disorders: Clinical Assessment and Management. The Guilford Press, NY, USA (1999)
15. Turgay A, Erman O, Oncu B. Comorbidities in child and adolescent conduct disorder. Presented at the Annual Scientific Meeting of the American Psychiatric Association. (2000).
16. Lalonde J, Turgay A, Hudson JI. Attention deficit hyperactivity disorder and comorbid disruptive behavior disorders in a child and adolescent mental health clinic. Can. J. Psychiatry 43, 623-628 (1998).
17. American Academy of Child and Adolescent Psychiatry. Practice parameters for the assessment and treatment of children, adolescents and adults with attention deficit/hyperactivity disorder J. Am. Acad. Child. Adolesc. Psychiatry 36(Suppl.), S85-S121 (1997).
18. Ambrossini P, Metz C, Probucki K et al. Videotape reliability of the third revised edition of the K-SADS. J. Am. Acad. Child. Adolesc. Psychiatry 39, 49-58 (2000).
19. Shaffer D, Fisher P, Lucas CP et al. Diagnostic interview schedule for children version IV (NIMH DISC-IV): description, differences from previous versions and reliability of some common diagnosis. J. Am. Acad. Child. Adolesc. Psychiatry 39, 28-38 (2000).
20. Herjanic B, Campbell W. Differentiating psychiatrically disturbed children on the basis of a structured interview. J. Abnorm. Child. Psych. 5, 127-134 (1977).
21. Achenbach T. Assesment and Taxonomy of Child and Adolescent Psychopathology. Sage, CA, USA (1985).
22. Offord D, Bennett K. Conduct disorder: long-term outcomes and intervention effectiveness. J. Am. Acad. Child. Adolesc. Psychiatry 33, 1069-1078 (1994).
23. Tolan P, Guerra N. Prevention of delinquency: current status and issues. Appl. Prevent. Psychol. 3, 251-273 (1994).
24. Henggeler S, Schoenwald S. Boot camps for juvenile offenders: just say no. J. Child Fam. Stud. 3, 243-248 (1994).
25. Henggeler S, Mann B, Borduin C, Blaske D. An investigation of systemic conceptualizations of parent-child coalitions and symptom change. J. Consult. Clin. Psychol. 58, 336-344 (1990).
26. Short R. Conduct disorders: a framework for understanding and intervention in schools and communities. Sch. Psychol. Rev. 22, 362-275 (1993).
27. Webster-Stratton C. Strategies for helping early school-aged children with oppositional defiant disorder.
28. Abikoff H, Klein R. Attention deficit hyperactivity disorder and conduct disorder: comorbidity and implications for treatment. J. Consult. Clin. Psychol. 60, 881-892 (1993).
29. Grizenko N, Papineau D, Sayegh L. Effectiveness of a multimodal day treatment program for children with disruptive behavior problems. J. Am. Acad. Child. Adolesc. 32, 127-134 (1993).
30. Shamsie J, Sykes C, Hamilton H. Continuity of care for conduct disordered youth. Can. J. Psychiatry 39, 415-420 (1994). Provides a good summary of the integration of multiple intervention strategies in caring for conduct disorder youth and promotes long-term follow-up.
31. Mulvey E, Arthur M, Reppucci N. The prevention and treatment of juvenile delinquency: a review of the research. Clin. Psychol. Rev. 13, 133-167 (1993).
32. Smith PK, Brain P. Bullying in schools: lessons from two decades of research. Aggressive Behav. 26, 1-9 (2000).
33. Cowles E, Castellano T, Gransky L. 'Boot camp' drug treatment and aftercare interventions: an evaluation review. Research in Brief. National Institute of Justice, Washington DC, USA (1995).
34. Kazdin A. Hospitalization of antisocial children: clinical course, follow-up status and predictors of outcome. Adv. Behav. Res. Ther. 11, 1-67 (1989).
35. Mendel R. Prevention or pork? A hard-headed look at youth-oriented anticrime programs. American Youth Policy Forum, Washinton DC, USA (1995).
36. McCord J, Tremblay R, Vitaro F, Desmarais-Gervais L. Boys' disruptive behaviour, school adjustment and delinquency: the Montreal prevention experiment. Int. J. Behav. Dev. 17, 739-752 (1994).
37. Patterson G, Narrett C. The development of a reliable and valid treatment program for aggressive young children. Int. J. Mental Health 19, 19-26 (1990).
38. Patterson G, DeBaryshe B, Ramsey E. A developmental perspective on antisocial behavior. Am. Psychol. 44, 329-335 (1989).
39. Turgay A, Erman O, Oncu B, Ansari R, Urdarevic V. Comorbidities in conduct disorder may determine the type of medication treatment. Can. Ped. Soc. (2002).
40. Wells K. Parent management training. In: Conduct Disorders in Children and Adolescents. Sholevar P (Ed.). American Psychiatric Press, Washington DC, USA 213-236 (1995).
41. Kazdin A. Child and adolescent dysfunction and paths toward maladjustment: targets for intervention. Clin. Psychol. Rev. 12, 795-817 (1992).
42. Stormshak EA, Bierman KL, McMahon RJ, Lengua LJ. Parenting practices and child disruptive behavior problems in early elementary school. J. Clin. Child. Psychol. 29, 17-29 (2000).
43. Fonagy P, Target M. The efficacy of psychoanalysis for children with disruptive disorders. J. Am. Acad. Child Adolesc. Psychiatry 33, 45-55 (1993).
44. Steiner H, Huckaby W. Adaptation in incarcerated juvenile offenders. Scientific proceedings of the 36th Annual Meeting of the American Academy of Child and Adolescent Psychiatry, NY, USA (1989).
45. Steiner H, Garcia I, Huckaby W. Recidivism along personality dimensions. Scientific proceedings of the Annual Meeting of the American Academy of Child and Adolescent Psychiatry, CA, USA (1993).
46. Tinklenberg J, Steiner H, Huckaby W. Criminal recidivism predicted from narratives of violent juvenile delinquents. Child Psychiatry Hum. Dev. 27, 69-79 (1996).
47. Aichhorn A. Wayward Youth. Viking, NY, USA (1935).
48. Feldman S, Weinberger D. Self-restraint as a mediator of family influences on boys' delinquent behavior: a longitudinal study. Child. Dev. 65, 195-211 (1994).
49. Borduin C, Mann B, Cone L et al. Multisystemic treatment of serious juvenile offenders: long-term prevention of criminality and violence. J. Consult. Clin. Psychol. 63, 569-578 (1995).
50. Henggeler S, Borduin C, Mann B. Intrafamily agreement: association with clinical status, social desirability and observational ratings. J. Appl. Dev. Psychol. 8, 97-111 (1987).
51. Henggeler S, Edwards J, Borduin C. The family relations of female juvenile delinquents. J. Abnorm. Child. Psychol. 15, 199-209 (1987).
52. Lipsey M. Juvenile delinquency treatment: a meta-analytic inquiry into the variability of effects. In: Meta-Analysis for Explanation. Russell Sage Foundation, USA, 83-128 (1992).
53. Hinshaw S, Heller T, McHale J. Covert antisocial behavior in boys with attention deficit hyperactivity disorder: external validation and effects of methylphenidate. J. Consult. Clin. Psychol. 60, 264-271 (1992).
54. Klien R, Abikoff H, Klass E, Ganales D, Seese L, Pollack S. Clinical efficacy of methylphenidate in conduct disorder with and without attention deficit hyperactivity disorder. Arch. Gen. Psychiatry 54, 1073-1080 (1997).
55. American Academy of Child and Adolescent Psychiatry. Practice parameter of the use of stimulant medications in the treatment of children, adolescents and adults. J. Am. Acad. Child. Adolesc. Psychiatry 41(Suppl.), S26-S49 (2002). Since many children and adolescents with conduct disorder have associated attention deficit hyperactivity disorder (ADHD), the Academy guidelines are useful in developing a sequence for treatment options.
56. Campbell M. The pharmacological treatment of conduct disorders and rage outbursts. Psychiatr. Clin. North Am. 15, 69-851 (1992). Outlines the use of antipsychotics and mood regulators based on her earlier double-blind placebo-controlled studies with practical suggestions for initiation and maintenance of dosing.
57. American Academy of Child and Adolescent Psychiatry. Practice parameters for the assessment and treatment of conduct disorders. J. Am. Acad. Child Adolesc. Psychiatry 31, 4-7 (1992).
58. Hinshaw S, Buhrmester D, Heller T. Anger control in response to verbal provocation: effects of stimulant medication for boys with ADHD. J. Abnorm. Child. Psychol. 17, 393-407 (1989).
59. Pelham WE, Gnagy EM, Burrows-Maclen L et al. Once-a-day Concerta Methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings. Pediatrics 107, 105 (2001). Concerta provides 12 h symptom control and provides not only convenience but a better compliance to control the symptoms of ADHD. Outlines the differences from short-acting medications.
60. Lavin M, Rifkin A. Diagnosis and pharmacotherapy of conduct disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 17, 875-885 (1993).
61. Michelson D, Faries D, Wernicke J et al. and the atomoxetine ADHD study group. Atomoxetine in the treatment of children and adolescents with attention deficit/ hyperactivity disorder: a randomized, placebo-controlled, dose-response study. Pediatrics 108, 83 (2001). Atomoxetine is a nonstimulant medication with continues symptoms control for ADHD and oppositional defiant behavior. Thus study outlines the major findings of a multisite study and may be useful for physicians who are interested in use of this medicine as either a first line or an alternative to stimulants.
62. Kratochvil C, Heiligenstein JH, Dittmann R et al. Atomoxetine and methylphenidate treatment in ADHD children: a randomized, open-label trial. Presented at American Academy of Child and Adolescent Psychiatry, HI, USA, October 23-28. (2001).
63. Kratochvil C, Wernicke JF, Michelson D et al. Long-term safety of atomoxetine in the treatment of ADHD. Presented at American Academy of Child and Adolescent Psychiatry, HI, USA, October 23-28. (2001).
64. Brown WJ, Wernicke J, Michelson D, Harder D, Milton D, Kelsey D. Efficacy of atomoxetine in children and adolescents with attention deficit hyperactivity disorder. Johns Hopkins University School of Medicine. Advanc. Studies Med. 2, 928-929 (2002).
65. Werry JS, Aman MG. Anxiolytics, sedatives and miscellaneous drugs. In: Practitioner's Guide to Psychoactive Drugs for Children and Adolescents. Second Edition. Werry JS, Aman MG (Eds). Plenum, NY, USA, 433-469 (1999).
66. Buitelaar JK. Open-label treatment with risperidone of 26 psychiatrically-hospitalized children and adolescents with mixed diagnoses and aggressive behavior. J. Child Adoles. Psychopharmacol. 10(1), 19-26 (2000).
67. Snyder R, Turgay A, Aman M, Binder C, Fisman S, Carrol A and the risperidone study group. Effects of risperone on conduct and disruptive behavior disorders in children with subaverage IQs. J. Am. Acad. Child. Adolesc. Psychiatry 41(9), 1026-1036 (2002).
68. Turgay A, Binder C, Snyder R, Fisman S. Long-term safety and efficacy of risperidone for the treatment of disruptive behavior disorders in children with subaverage IQs. Pediatrics 110, 34 (2002).
69. Turgay A, Snyder R, Fisman S, Carroll A, Aman M, Binder C and the Conduct Disorder Research Group. A new generation antipsychotic risperidone (Risperdal) vs. placebo for severe conduct disorder in children with mental retardation. In: Advances in the Treatment of Child and Adolescent Psychiatric Disorders. Johnston HF (Ed.). University of Wisconsin Continuing Education Program, WI, USA, 28-29 (2003).
70. Fisman S, Snyder R, Turgay A, Binder C and Conduct Disorder Study Group. Long-term safety and efficacy of risperidone in children with subaverage IQ and disruptive behavior disorders. In: Advances in the Treatment of Child and Adolescent Psychiatric Disorders. Johnston HF (Ed.). University of Wisconsin Continuing Education Program, WI, USA, 14-15 (2003).
71. Yildiz A, Turgay A, Alpay M, Sachs GS. Observational data on the anti-agitation effect of risperidone tablets in emergency settings: a preliminary report. Int. J. Psych. Clin. Practice. (2003) (In Press).
72. Yildiz A, Sachs GS, Turgay A. Pharmacological management of agitation in emergency settings. Emergency Medicine J. 20, 339-346 (2003).
73. Botteron K, Geller B. Disorders, symptoms and their pharmacology. In: Practitioner Guide to Psychoactive Drugs. Second Edition. Wery JS, Aman MG (Eds). Plenum, NY, USA, 183-209 (1999).
74. Fava M. Psychopharmacologic treatment of pathologic aggression. Psychiatr. Clin. North Am. 20, 427-451 (1997).
75. Donovan SJ, Stewart JW, Nunes EV et al. Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design. Am. J. Psychiatry 157, 818-820 (2000).
76. Green WH. Child and Adolescent Clinical Psychopharmacology. Lipcott Williams & Wilkins, NY, USA (2001).